Exagen to Present at Cowen and Company 40th Annual Healthcare Conference
February 18 2020 - 8:25AM
Exagen Inc. (Nasdaq: XGN), an organization dedicated to
transforming the care continuum for patients suffering from
debilitating and chronic autoimmune diseases by enabling timely
differential diagnosis and optimizing therapeutic intervention,
today announced that Ron Rocca, CEO of Exagen, will present at the
Cowen and Company 40th Annual Healthcare Conference on Monday,
March 2, 2020 in Boston. Mr. Rocca’s presentation will take
place at 3:30 p.m. EST.
A link to the live webcast of the presentation will be available
online from the investor relations section of the Exagen website at
https://investors.exagen.com/
A replay of the webcast will be accessible on the Exagen
investor relations website beginning approximately one hour
following the completion of the event.
About Exagen Inc.
Exagen is dedicated to transforming the care continuum for
patients suffering from debilitating and chronic autoimmune
diseases by enabling timely differential diagnosis and optimizing
therapeutic intervention. Exagen has developed and is
commercializing a portfolio of innovative testing products under
its AVISE® brand, several of which are based on its proprietary
Cell-Bound Complement Activation Products, or CB-CAPs, technology.
Exagen’s goal is to enable rheumatologists to improve care for
patients through the differential diagnosis, prognosis and
monitoring of complex autoimmune and autoimmune-related diseases,
including SLE and rheumatoid arthritis.
CONTACTS:
InvestorsWestwicke Partners Mike
CavanaughMike.Cavanaugh@westwicke.com646.677.1838 Company
ContactExagen Inc. Kamal Adawi, Chief Financial
OfficerKAdawi@exagen.com760.477.5514
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Sep 2023 to Sep 2024